超高效液相色谱-四极杆飞行时间质谱法测定血液与尿液中赛拉嗪及代谢产物2,6-二甲基苯胺

建立了一种超高效液相色谱-串联四极杆飞行时间质谱同时测定血液和尿液中赛拉嗪及2,6-二甲基苯胺的分析方法。样品经乙酸乙酯-正己烷(1∶1,体积比)提取,C18色谱柱分离,电喷雾正电离条件下进行全离子扫描模式检测。借助分析软件,通过对化合物离子精确质荷比、同位素轮廓丰度、特征二级质谱以及保留时间的比对,对目标物进行验证。方法的回收率为72.5%~87.8%,相对标准偏差为6.8%~9.7%。赛拉嗪在血液和尿液中的检出限分别为0.2,0.1μg/L,定量下限分别为0.6,0.3μg/L;2,6-二甲基苯胺在血液和尿液中的检出限分别为0.5,0.3μg/L,定量下限分别为1.5,1.0μg/L。方法快速、灵敏度高、重现性好,适用于中毒人体的血液和尿液中赛拉嗪及2,6-二甲基苯胺的检测。     

Characterization of xylazine metabolism in rat liver microsomes using liquid chromatography–hybrid triple quadrupole–linear ion trap–mass spectrometry

ABSTRACT: Xylazine is an α₂‐adrenoceptor agonist and it is widely used in veterinary anesthesia in combination with ketamine. There is limited information on the metabolism of xylazine. A quantitative method for the determination of xylazine by HPLC‐ESI/MS/MS was developed. The method consisted of a protein precipitation extraction followed by analysis using liquid chromatography electrospray tandem mass spectrometry. The chromatographic separation was achieved using a Thermo Betasil Phenyl 100 × 2 mm column combined with an isocratic mobile phase composed of acetonitrile, methanol, water and formic acid (60:20:20:0.4) at a flow rate of 300 μL/min. The mass spectrometer was operating in selected reaction monitoring mode and the analytical range was set at 0.05–50 μm . The precision (%CV) and accuracy (%NOM) observed were 2.3–7.2 and 88.2–96.4%. In vitro metabolism studies were performed in rat liver microsomes and results showed moderate cytochrome P450 affinity (K_m = 10.1 μm ) and a low metabolic stability of xylazine with a half‐life of 4.1 min in rat liver microsomes. Five phase 1 metabolites were observed. The main metabolite observed was an oxidation of the thiazine moiety at m/z 235 and, to a lesser extent, we observed the formation of N‐(2,6‐dimethylphenyl)thiourea at m/z 181 and three distinctive hydroxylated metabolites at m/z 237. Further experiments with ketamine and ketoconazole strongly supported that the metabolism of xylazine to its main metabolite is mediated by CYP3A in rat liver microsomes. Copyright © 2013 John Wiley & Sons, Ltd.